- Poster presentation
- Open access
- Published:
Clinical status course and quality of life after the first 2 years of treatment: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
Annals of General Psychiatry volume 5, Article number: S144 (2006)
Background
European SOHO is a prospective, observational study of antipsychotic treatment in 10 European countries.
Materials and methods
Clinical effectiveness and Qol were assessed using the Clinical Global Impression (CGI) scale and the EQ-5D instrument, respectively. For analysis, the 2-year period was split into four 6-month epochs (0–6, 6–12, 12–18 and 18–24 months). Multivariate modelling was performed, adjusting for baseline differences among patients.
Results
Olanzapine-treated patients had statistically higher overall CGI improvements during i) the first 6 months, compared with risperidone (0.20; 0.14–0.26), quetiapine (0.24; 0.15–0.33), amisulpride (0.12; 0.00–0.23), oral (0.33; 0.25–0.41) and depot typicals (0.33; 0.24–0.42) treated patients, and ii) second 6 months compared with oral typicals (0.12; 0.04–0.19) treated patients. No statistical separation was observed between the olanzapine and clozapine groups.
Olanzapine-treated patients had statistically higher EQ-5D utility improvements during the first 6 months compared with risperidone (0.034; 0.015–0.053), quetiapine (0.033; 0.010–0.061), amisulpride (0.043; 0.006–0.080), oral (0.075; 0.050–0.100) and depot typicals (0.073; 0.045–0.102) treated patients. No statistical separation was observed between the olanzapine and clozapine groups.
Discussion
Olanzapine appears to have a range of modest effectiveness and Qol advantages, appearing during the first 6 months of treatment and remaining thereafter, over other antipsychotic medications, except clozapine.
Author information
Authors and Affiliations
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Touloumis, C., Drossinos, V., Kyrana, M. et al. Clinical status course and quality of life after the first 2 years of treatment: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Ann Gen Psychiatry 5 (Suppl 1), S144 (2006). https://doi.org/10.1186/1744-859X-5-S1-S144
Published:
DOI: https://doi.org/10.1186/1744-859X-5-S1-S144